Spots Global Cancer Trial Database for A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
Official Title: A Phase I Study of Oral Topotecan in Subjects With Cancer and Impaired Renal Function
Study ID: NCT00483860
Conditions
Interventions
Study Description
Brief Summary: To determine the effect of renal impairment and prior platinum-based chemotherapy on the safety and blood levels of topotecan administered orally
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Scottsdale, Arizona, United States
GSK Investigational Site, Lebanon, New Hampshire, United States
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Utrecht, , Netherlands
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
